The Wisconsin Department of Health Services (DHS) is participating in the Centers for Medicare & Medicaid Services’ (CMS’) Cell and Gene Therapy Access Model. This model allows DHS to enter into enhanced rebate agreements with the manufacturers of two State-Selected Model Drugs, Casgevy and Lyfgenia.
Resources
Because you have not recently performed an action that loads or reloads a page, your session will expire in Upon expiration your unsaved data will be lost and you will be required to login again to begin a new session. To avoid a session expiration, click this button to extend your session.
Extend